Over and above its pain-relieving outcomes, conolidine has demonstrated a favorable basic safety margin in preclinical toxicology assessments. In contrast to opioids, which frequently lead to respiratory despair at larger doses, conolidine hasn't generated signs of considerable respiratory suppression. Additionally, behavioral assessments in murine